Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Summers

Showing results (411-420 of 717) with videos related to

Pageof 72
Sort By:
The Cornell Veterinarian|July 1, 1983
Intoxication by Solanum fastigiatum var. fastigiatum as a cause of cerebellar degeneration in cattleF Riet-Correa, M D Mendez, A L Schild, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|September 3, 2010
Paraneoplastic hypercalcemia in a dog with benign renal angiomyxomaIsuru Gajanayake, Simon L Priestnall, Livia Benigni, et al.
Environmental Management|December 7, 2013
Investigation of biogeochemical functional proxies in headwater streams across a range of channel and catchment alterationsJacob F Berkowitz, Elizabeth A Summers, Chris V Noble, et al.
European Heart Journal Open|May 5, 2025
The role of sphingolipids in heart failureRana Hamouche, Scott A Summers, William L Holland, et al.
Wiener Klinische Wochenschrift|February 27, 1999
Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogsR K Straubinger, A F Straubinger, B A Summers, et al.
FEBS Letters|July 11, 1994
Substitution of conserved tyrosine residues in helix 4 (Y143) and 7 (Y293) affects the activity, but not IAPS-forskolin binding, of the glucose transporter GLUT4S Wandel, A Schürmann, W Becker, et al.
Molecular Genetics and Metabolism|February 26, 2018
Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouseMatthew A Summers, Emily R Vasiljevski, Kathy Mikulec, et al.
Bioorganic & Medicinal Chemistry|November 10, 2018
Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymesAngelica R Harper, Anh T Le, Timothy Mather, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2003
A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effectsMonica A Summers, M Sue O'Dorisio, Mary O Cox, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1995
Mutation of two conserved arginine residues in the glucose transporter GLUT4 supresses transport activity, but not glucose-inhibitable binding of inhibitory ligandsS Wandel, A Schurmann, W Becker, et al.
Pageof 72

Showing results (411-420 of 717) with videos related to

Sort By:
Pageof 72
The Cornell Veterinarian|July 1, 1983
Intoxication by Solanum fastigiatum var. fastigiatum as a cause of cerebellar degeneration in cattleF Riet-Correa, M D Mendez, A L Schild, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|September 3, 2010
Paraneoplastic hypercalcemia in a dog with benign renal angiomyxomaIsuru Gajanayake, Simon L Priestnall, Livia Benigni, et al.
Environmental Management|December 7, 2013
Investigation of biogeochemical functional proxies in headwater streams across a range of channel and catchment alterationsJacob F Berkowitz, Elizabeth A Summers, Chris V Noble, et al.
European Heart Journal Open|May 5, 2025
The role of sphingolipids in heart failureRana Hamouche, Scott A Summers, William L Holland, et al.
Wiener Klinische Wochenschrift|February 27, 1999
Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogsR K Straubinger, A F Straubinger, B A Summers, et al.
FEBS Letters|July 11, 1994
Substitution of conserved tyrosine residues in helix 4 (Y143) and 7 (Y293) affects the activity, but not IAPS-forskolin binding, of the glucose transporter GLUT4S Wandel, A Schürmann, W Becker, et al.
Molecular Genetics and Metabolism|February 26, 2018
Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouseMatthew A Summers, Emily R Vasiljevski, Kathy Mikulec, et al.
Bioorganic & Medicinal Chemistry|November 10, 2018
Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymesAngelica R Harper, Anh T Le, Timothy Mather, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2003
A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effectsMonica A Summers, M Sue O'Dorisio, Mary O Cox, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1995
Mutation of two conserved arginine residues in the glucose transporter GLUT4 supresses transport activity, but not glucose-inhibitable binding of inhibitory ligandsS Wandel, A Schurmann, W Becker, et al.
Pageof 72